Protocol CCTG-NE.1 "NET RETREAT: A phase II study of 177Lutetium-DOTATATE retreatment vs. everolimus in metastatic/unresectable midgut NET"
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Emily Baiyee Toegel](https://researchstudies.cuanschutz.edu/Content/images/investigators/no-photo.jpg)
Emily Baiyee Toegel
Study ID
Protocol Number: 23-1917
More information available at ClinicalTrials.gov: NCT05773274
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers